Summary & Overview

HCPCS Level II J0891: Argatroban Injection, 1 mg

HCPCS Level II code J0891 designates the injection of argatroban (accord), 1 mg, for non‑ESRD use and is billed for parenteral anticoagulant therapy. This pharmaceutical HCPCS code matters nationally because argatroban is used as an alternative anticoagulant in patients with heparin contraindications, and clear coding ensures accurate drug identification, payment, and utilization tracking across inpatient and outpatient settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical role and billing context, an overview of typical sites of service where J0891 is used, and what to expect in payer coverage and claims processing. The publication also outlines common modifiers and coding considerations, highlights differences from therapeutically related codes such as J0883, and summarizes benchmarks and policy updates relevant to drug coding and reimbursement. Where specific payer policy details, taxonomies, or ICD‑10 pairings are not provided, the text notes that data are not available in the input.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0891HCPCS Level IIargatrobananticoagulantinjectiondrug codinginfusionbilling

Billing Code Overview

HCPCS Level II code J0891 represents the injection of argatroban (accord), 1 mg, specifically noted as not therapeutically equivalent to J0883 and intended for non‑ESRD use. The code describes the pharmaceutical product and its unit dosing for billing purposes.

Service Type: Pharmacologic anticoagulant injection

Typical Site of Service: Hospital inpatient, hospital outpatient infusion centers, and other outpatient clinic settings where parenteral anticoagulant therapy is administered

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A typical patient is a hospitalized adult requiring systemic anticoagulation for treatment or prophylaxis of thrombosis when heparin products are contraindicated, most commonly due to heparin‑induced thrombocytopenia (HIT) or a severe heparin allergy. The patient often presents with acute deep vein thrombosis, pulmonary embolism, or is undergoing vascular procedures where alternative anticoagulation is required. Argatroban is administered intravenously by trained inpatient pharmacy and nursing staff in an acute care setting such as an intensive care unit, step‑down unit, cardiac cath lab, or operating room depending on procedural needs.

Clinical workflow typically includes:

Order entry by the treating physician with indication documented (e.g., HIT or procedural anticoagulation).
Baseline labs obtained prior to initiation: liver function tests, activated partial thromboplastin time (aPTT), complete blood count.
Pharmacy prepares J0891 (argatroban) dosage per weight and hepatic function; nurse documents lot, quantity, and syringe/infusion labeling.
Administration by infusion pump with titration to target aPTT range and serial monitoring; adjustments documented in medication administration record.
Transition planning if long‑term anticoagulation is required (e.g., to a direct oral anticoagulant or warfarin) with overlap considerations and documented plan.
Billing captures J0891 for the drug product per milligram dispensed; appropriate modifier(s) appended as required by payer policy and clinical circumstance.

Coding Specifications

Modifier	Description	When to Use
`00`	Default/No modifier	When no specific modifier applies to the service.
`22`	Increased procedural services	When administration required substantially greater effort or resources (rare for drug billing; used for associated procedures).
`23`	Unusual anesthesia	Not commonly applied to `J0891`; used if anesthesia unrelated to the primary procedure is provided.
`52`	Reduced services	When the full drug dose or service was partially reduced and documented.
`53`	Discontinued procedure	If infusion initiated but discontinued before completion for documented clinical reasons.
`62`	Two surgeons	Applied to procedural services when two surgeons are required; may affect related procedure billing.
`78`	Return to OR for a related procedure during global period	When a patient returns to the operating room for a related procedure; can affect bundled services.
`80`	Assistant surgeon	When an assistant surgeon is documented for an associated operative procedure.
`82`	Assistant (when qualified resident unavailable)	Similar to `80` when no resident is available.
`AS`	New technology add‑on? (payer‑specific)	Used per payer policy when applicable to novel drug administration programs.
`JW`	Drug discarded/not administered	When a portion of the single‑use drug vial is discarded and must be reported per payer rules.
`QK`	Medical direction of two or more CRNAs by a physician	Relevant to anesthesia services tied to procedures requiring argatroban.
`QX`	CRNA service with medical direction by a physician	As above; applies to anesthesia components of associated procedures.

Taxonomy Code	Specialty	Notes
`208D00000X`	Hematology	Manages HIT diagnosis and anticoagulation strategies.
`207L00000X`	Cardiovascular Disease	Manages thrombotic events such as pulmonary embolism and peri‑procedural anticoagulation.
`208M00000X`	Medical Oncology (and Hematology)	Inpatients with cancer‑associated thrombosis requiring argatroban when heparin contraindicated.
`363A00000X`	Critical Care Medicine	Prescribes and oversees anticoagulation in critically ill patients.
`207P00000X`	Interventional Cardiology	Uses argatroban for procedural anticoagulation during cath/PCI when heparin is contraindicated.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D75.82`	Heparin‑induced thrombocytopenia (HIT)	Primary indication for use of argatroban when heparin products are contraindicated.
`I82.40`	Acute embolism and thrombosis of unspecified deep veins of lower extremity	Venous thromboembolism where alternative anticoagulation with argatroban may be used if heparin contraindicated.
`I26.99`	Other pulmonary embolism without acute cor pulmonale	Pulmonary embolism requiring anticoagulation when heparin cannot be used.
`I74.9`	Arterial embolism and thrombosis, unspecified	Arterial thrombotic events sometimes managed with non‑heparin anticoagulants.
`Z79.01`	Long term (current) use of anticoagulants	Documented when ongoing anticoagulant therapy is part of the care plan; helps justify management and monitoring.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36415`	Collection of venous blood by venipuncture	Baseline and monitoring labs (aPTT, CBC, liver function) required for argatroban dosing and monitoring.
`96365`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour	May be used for billing infusion setup and initial infusion time when argatroban administered as a monitored IV infusion in outpatient infusion settings, subject to payer rules.
`96366`	Intravenous infusion; each additional hour	Used for additional infusion time when argatroban infusion continues beyond first hour and billing for infusion time is applicable.
`92950`	Cardiopulmonary resuscitation (CPR)	Emergency code to indicate resuscitation events that may occur in complex anticoagulated patients; documents emergent services but not routine to argatroban administration.
`93797`	Anticoagulation management for a patient on warfarin or other oral anticoagulant therapy	Represents anticoagulation management services (education, dosage adjustments, monitoring) analogous to services required when transitioning from argatroban to oral anticoagulation; may be used by clinics providing management services.